RSS-Feed abonnieren
DOI: 10.5999/aps.2012.39.5.504
Does Fibrin Sealant Reduce Seroma after Immediate Breast Reconstruction Utilizing a Latissimus Dorsi Myocutaneous Flap?
Background The most common complication of latissimus dorsi myocutaneous flap in breast reconstruction is seroma formation in the back. Many clinical studies have shown that fibrin sealant reduces seroma formation. We investigated any statistically significant differences in postoperative drainage and seroma formation when utilizing the fibrin sealant on the site of the latissimus dorsi myocutaneous flap harvested for immediate breast reconstruction after skin-sparing partial mastectomy.
Methods A total of 46 patients underwent immediate breast reconstruction utilizing a latissimus dorsi myocutaneous island flap. Of those, 23 patients underwent the procedure without fibrin sealant and the other 23 were administered the fibrin sealant. All flaps were elevated with manual dissection by the same surgeon and were analyzed to evaluate the potential benefits of the fibrin sealant. The correlation analysis and Mann-Whitney U test were used for analyzing the drainage volume according to age, weight of the breast specimen, and body mass index.
Results Although not statistically significant, the cumulative drainage fluid volume was higher in the control group until postoperative day 2 (530.1 mL compared to 502.3 mL), but the fibrin sealant group showed more drainage beginning on postoperative day 3. The donor site comparisons showed the fibrin sealant group had more drainage beginning on postoperative day 3 and the drain was removed 1 day earlier in the control group.
Conclusions The use of fibrin sealant resulted in no reduction of seroma formation. Because the benefits of the fibrin sealant are not clear, the use of fibrin sealant must be fully discussed with patients before its use as a part of informed consent.
This article was presented at the 69th congress of the Korean Society of Plastic and Reconstructive Surgeons on November 11-13, 2011 in Seoul, Korea.
Publikationsverlauf
Eingereicht: 25. März 2012
Angenommen: 02. Juli 2012
Artikel online veröffentlicht:
01. Mai 2022
© 2012. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
REFERENCES
- 1 Scheflan M, Kalisman M. Complications of breast reconstruction. Clin Plast Surg 1984; 11: 343-350
- 2 Davis JP, Nield DV, Garth RJ. et al. The latissimus dorsi flap in head and neck reconstructive surgery: a review of 121 procedures. Clin Otolaryngol Allied Sci 1992; 17: 487-490
- 3 Salmi A, Tukiainen E, Harma M. et al. A prospective study of changes in muscle dimensions following free-muscle transfer measured by ultrasound and CT scanning. Plast Reconstr Surg 1996; 97: 1443-1450
- 4 Kulber DA, Bacilious N, Peters ED. et al. The use of fibrin sealant in the prevention of seromas. Plast Reconstr Surg 1997; 99: 842-849
- 5 Wang JY, Goodman NC, Amiss Jr LR. et al. Seroma prevention in a rat mastectomy model: use of a light-activated fibrin sealant. Ann Plast Surg 1996; 37: 400-405
- 6 Spotnitz WD. Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost 1995; 74: 482-485
- 7 Reddick LP. Seroma after latissimus dorsi myocutaneous flap for breast reconstruction. Plast Reconstr Surg 1990; 85: 826
- 8 Slavin AS. Seroma after latissimus dorsi myocutaneous flap for breast reconstruction-reply (letter). Plast Reconstr Surg 1990; 85: 826
- 9 Coons MS, Folliguet TA, Rodriguez C. et al. Prevention of seroma formation after dissection of musculocutaneous flaps. Am Surg 1993; 59: 215-218
- 10 Dancey AL, Cheema M, Thomas SS. A prospective randomized trial of the efficacy of marginal quilting sutures and fibrin sealant in reducing the incidence of seromas in the extended latissimus dorsi donor site. Plast Reconstr Surg 2010; 125: 1309-1317
- 11 Friedlander L, Sundin J. Minimally invasive harvesting of the latissimus dorsi. Plast Reconstr Surg 1994; 94: 881-884
- 12 Radosevich M, Goubran HI, Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang 1997; 72: 133-143
- 13 Gilly FN, Francois Y, Sayag-Beaujard AC. et al. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res 1998; 30: 439-443
- 14 Gioffre Florio MA, Mezzasalma F, Manganaro T. et al. The use of fibrin glue in the surgery of breast carcinoma. G Chir 1993; 14: 239-241
- 15 Vaxman F, Kolbe A, Stricher F. et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res 1995; 27: 346-352